|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
294 a.a.
|
 |
|
|
|
|
|
|
|
258 a.a.
|
 |
|
|
|
|
|
|
|
279 a.a.
|
 |
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
Cdk2/cyclin a in complex with an 11-residue recruitment peptide from retinoblastoma-associated protein
|
|
Structure:
|
 |
Cell division protein kinase 2. Chain: a, c. Synonym: cyclin-dependent kinase 2, p33 protein kinase. Engineered: yes. Cyclin a2. Chain: b, d. Fragment: cyclin fold, residues 175-432. Synonym: cyclin a. Engineered: yes.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Organism_taxid: 9606
|
|
Biol. unit:
|
 |
Dimer (from PDB file)
|
|
Resolution:
|
 |
|
2.5Å
|
R-factor:
|
0.249
|
R-free:
|
0.266
|
|
|
Authors:
|
 |
I.Tews,K.Y.Cheng,E.D.Lowe,M.E.M.Noble,N.R.Brown,S.Gul, S.Gamblin,L.N.Johnson
|
Key ref:
|
 |
E.D.Lowe
et al.
(2002).
Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Biochemistry,
41,
15625-15634.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
31-Jul-02
|
Release date:
|
01-Feb-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P24941
(CDK2_HUMAN) -
Cyclin-dependent kinase 2
|
|
|
|
Seq: Struc:
|
 |
 |
 |
298 a.a.
294 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, C:
E.C.2.7.11.22
- Cyclin-dependent kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + a protein = ADP + a phosphoprotein
|
 |
 |
 |
 |
 |
ATP
|
+
|
protein
|
=
|
ADP
|
+
|
phosphoprotein
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
cyclin-dependent protein kinase holoenzyme complex
|
15 terms
|
 |
|
Biological process
|
regulation of gene silencing
|
34 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
13 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
41:15625-15634
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
|
|
E.D.Lowe,
I.Tews,
K.Y.Cheng,
N.R.Brown,
S.Gul,
M.E.Noble,
S.J.Gamblin,
L.N.Johnson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Progression through S phase of the eukaryotic cell cycle is regulated by the
action of the cyclin dependent protein kinase 2 (CDK2) in association with
cyclin A. CDK2/cyclin A phosphorylates numerous substrates. Substrate
specificity often employs a dual recognition strategy in which the sequence
flanking the phospho-acceptor site (Ser.Pro.X.Arg/Lys) is recognized by CDK2,
while the cyclin A component of the complex contains a hydrophobic site that
binds Arg/Lys.X.Leu ("RXL" or "KXL") substrate recruitment
motifs. To determine additional sequence specificity motifs around the RXL
sequence, we have performed X-ray crystallographic studies at 2.3 A resolution
and isothermal calorimetry measurements on complexes of phospho-CDK2/cyclin A
with a recruitment peptide derived from E2F1 and with shorter 11-mer peptides
from p53, pRb, p27, E2F1, and p107. The results show that the cyclin recruitment
site accommodates a second hydrophobic residue either immediately C-terminal or
next adjacent to the leucine of the "RXL" motif and that this site
makes important contributions to the recruitment peptide recognition. The
arginine of the RXL motif contacts a glutamate, Glu220, on the cyclin. In those
substrates that contain a KXL motif, no ionic interactions are observed with the
lysine. The sequences N-terminal to the "RXL" motif of the individual
peptides show no conservation, but nevertheless make common contacts to the
cyclin through main chain interactions. Thus, the recruitment site is able to
recognize diverse but conformationally constrained target sequences. The
observations have implications for the further identification of physiological
substrates of CDK2/cyclin A and the design of specific inhibitors.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Schreiber,
and
A.E.Keating
(2011).
Protein binding specificity versus promiscuity.
|
| |
Curr Opin Struct Biol, 21,
50-61.
|
 |
|
|
|
|
 |
J.Y.Yoo,
S.H.Hwang,
Y.S.Han,
and
S.Cho
(2011).
Isolation and expression analysis of a homolog of the 14-3-3 epsilon gene in the diamondback moth, Plutella xylostella.
|
| |
Arch Insect Biochem Physiol, 76,
114-124.
|
 |
|
|
|
|
 |
A.C.Joerger,
and
A.R.Fersht
(2010).
The tumor suppressor p53: from structures to drug discovery.
|
| |
Cold Spring Harb Perspect Biol, 2,
a000919.
|
 |
|
|
|
|
 |
A.Hirschi,
M.Cecchini,
R.C.Steinhardt,
M.R.Schamber,
F.A.Dick,
and
S.M.Rubin
(2010).
An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.
|
| |
Nat Struct Mol Biol, 17,
1051-1057.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Xue,
A.K.Dunker,
and
V.N.Uversky
(2010).
Retro-MoRFs: Identifying Protein Binding Sites by Normal and Reverse Alignment and Intrinsic Disorder Prediction.
|
| |
Int J Mol Sci, 11,
3725-3747.
|
 |
|
|
|
|
 |
B.Xue,
R.L.Dunbrack,
R.W.Williams,
A.K.Dunker,
and
V.N.Uversky
(2010).
PONDR-FIT: a meta-predictor of intrinsically disordered amino acids.
|
| |
Biochim Biophys Acta, 1804,
996.
|
 |
|
|
|
|
 |
G.Pascreau,
F.Eckerdt,
M.E.Churchill,
and
J.L.Maller
(2010).
Discovery of a distinct domain in cyclin A sufficient for centrosomal localization independently of Cdk binding.
|
| |
Proc Natl Acad Sci U S A, 107,
2932-2937.
|
 |
|
|
|
|
 |
N.A.Copeland,
H.E.Sercombe,
J.F.Ainscough,
and
D.Coverley
(2010).
Ciz1 cooperates with cyclin-A-CDK2 to activate mammalian DNA replication in vitro.
|
| |
J Cell Sci, 123,
1108-1115.
|
 |
|
|
|
|
 |
A.Via,
C.M.Gould,
C.Gemünd,
T.J.Gibson,
and
M.Helmer-Citterich
(2009).
A structure filter for the Eukaryotic Linear Motif Resource.
|
| |
BMC Bioinformatics, 10,
351.
|
 |
|
|
|
|
 |
G.Kontopidis,
M.J.Andrews,
C.McInnes,
A.Plater,
L.Innes,
S.Renachowski,
A.Cowan,
and
P.M.Fischer
(2009).
Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
|
| |
ChemMedChem, 4,
1120-1128.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Orzáez,
A.Gortat,
L.Mondragón,
O.Bachs,
and
E.Pérez-Payá
(2009).
ATP-noncompetitive inhibitors of CDK-cyclin complexes.
|
| |
ChemMedChem, 4,
19-24.
|
 |
|
|
|
|
 |
S.Tyagi,
and
W.Herr
(2009).
E2F1 mediates DNA damage and apoptosis through HCF-1 and the MLL family of histone methyltransferases.
|
| |
EMBO J, 28,
3185-3195.
|
 |
|
|
|
|
 |
Z.Huang,
and
C.F.Wong
(2009).
Docking flexible peptide to flexible protein by molecular dynamics using two implicit-solvent models: an evaluation in protein kinase and phosphatase systems.
|
| |
J Phys Chem B, 113,
14343-14354.
|
 |
|
|
|
|
 |
A.C.Joerger,
and
A.R.Fersht
(2008).
Structural biology of the tumor suppressor p53.
|
| |
Annu Rev Biochem, 77,
557-582.
|
 |
|
|
|
|
 |
C.J.Oldfield,
J.Meng,
J.Y.Yang,
M.Q.Yang,
V.N.Uversky,
and
A.K.Dunker
(2008).
Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners.
|
| |
BMC Genomics, 9,
S1.
|
 |
|
|
|
|
 |
M.S.Cortese,
V.N.Uversky,
and
A.K.Dunker
(2008).
Intrinsic disorder in scaffold proteins: getting more from less.
|
| |
Prog Biophys Mol Biol, 98,
85.
|
 |
|
|
|
|
 |
G.Lolli,
and
L.N.Johnson
(2007).
Recognition of Cdk2 by Cdk7.
|
| |
Proteins, 67,
1048-1059.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.GawliĆski,
R.Nikolay,
C.Goursot,
S.Lawo,
B.Chaurasia,
H.M.Herz,
Y.Kussler-Schneider,
T.Ruppert,
M.Mayer,
and
J.Grosshans
(2007).
The Drosophila mitotic inhibitor Frühstart specifically binds to the hydrophobic patch of cyclins.
|
| |
EMBO Rep, 8,
490-496.
|
 |
|
|
|
|
 |
S.Tyagi,
A.L.Chabes,
J.Wysocka,
and
W.Herr
(2007).
E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.
|
| |
Mol Cell, 27,
107-119.
|
 |
|
|
|
|
 |
J.Sridhar,
N.Akula,
and
N.Pattabiraman
(2006).
Selectivity and potency of cyclin-dependent kinase inhibitors.
|
| |
AAPS J, 8,
E204-E221.
|
 |
|
|
|
|
 |
K.Y.Cheng,
M.E.Noble,
V.Skamnaki,
N.R.Brown,
E.D.Lowe,
L.Kontogiannis,
K.Shen,
P.A.Cole,
G.Siligardi,
and
L.N.Johnson
(2006).
The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition.
|
| |
J Biol Chem, 281,
23167-23179.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Otyepka,
I.Bártová,
Z.Kríz,
and
J.Koca
(2006).
Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics.
|
| |
J Biol Chem, 281,
7271-7281.
|
 |
|
|
|
|
 |
N.Canela,
M.Orzáez,
R.Fucho,
F.Mateo,
R.Gutierrez,
A.Pineda-Lucena,
O.Bachs,
and
E.Pérez-Payá
(2006).
Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A.
|
| |
J Biol Chem, 281,
35942-35953.
|
 |
|
|
|
|
 |
R.P.Bhattacharyya,
A.Reményi,
B.J.Yeh,
and
W.A.Lim
(2006).
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits.
|
| |
Annu Rev Biochem, 75,
655-680.
|
 |
|
|
|
|
 |
C.Gondeau,
S.Gerbal-Chaloin,
P.Bello,
G.Aldrian-Herrada,
M.C.Morris,
and
G.Divita
(2005).
Design of a novel class of peptide inhibitors of cyclin-dependent kinase/cyclin activation.
|
| |
J Biol Chem, 280,
13793-13800.
|
 |
|
|
|
|
 |
R.Honda,
E.D.Lowe,
E.Dubinina,
V.Skamnaki,
A.Cook,
N.R.Brown,
and
L.N.Johnson
(2005).
The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles.
|
| |
EMBO J, 24,
452-463.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Gildor,
R.Shemer,
A.Atir-Lande,
and
D.Kornitzer
(2005).
Coevolution of cyclin Pcl5 and its substrate Gcn4.
|
| |
Eukaryot Cell, 4,
310-318.
|
 |
|
|
|
|
 |
G.M.Verkhivker
(2004).
Protein conformational transitions coupled to binding in molecular recognition of unstructured proteins: hierarchy of structural loss from all-atom Monte Carlo simulations of p27Kip1 unfolding-unbinding and structural determinants of the binding mechanism.
|
| |
Biopolymers, 75,
420-433.
|
 |
|
|
|
|
 |
N.J.Dibb,
S.M.Dilworth,
and
C.D.Mol
(2004).
Switching on kinases: oncogenic activation of BRAF and the PDGFR family.
|
| |
Nat Rev Cancer, 4,
718-727.
|
 |
|
|
|
|
 |
N.Kannan,
and
A.F.Neuwald
(2004).
Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
|
| |
Protein Sci, 13,
2059-2077.
|
 |
|
|
|
|
 |
E.De Moliner,
N.R.Brown,
and
L.N.Johnson
(2003).
Alternative binding modes of an inhibitor to two different kinases.
|
| |
Eur J Biochem, 270,
3174-3181.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Y.Cheng,
E.D.Lowe,
J.Sinclair,
E.A.Nigg,
and
L.N.Johnson
(2003).
The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.
|
| |
EMBO J, 22,
5757-5768.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |